Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,433 | 42,256 | 125,206 | 66,874 | 65,076 |
| Marketable Securities | 188,679 | 156,475 | 143,685 | 89,375 | 46,366 |
| Receivables | 5,163 | 2,231 | 1,112 | 24 | 12 |
| Other current assets | 0 | 4,554 | 0 | 0 | 0 |
| TOTAL | $233,752 | $207,674 | $274,295 | $158,633 | $113,107 |
| Non-Current Assets | |||||
| PPE Net | 4,530 | 3,204 | 3,568 | 3,637 | 1,751 |
| Investments And Advances | 42,650 | 0 | 16,518 | 7,672 | 179 |
| Other Non-Current Assets | 8,882 | 300 | 429 | 200 | 200 |
| TOTAL | $56,062 | $3,504 | $20,515 | $11,509 | $2,130 |
| Total Assets | $289,814 | $211,178 | $294,810 | $170,142 | $115,237 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,607 | N/A | 2,500 | N/A |
| Accounts payable and accrued liabilities | 8,160 | 3,764 | 5,253 | 4,236 | 2,238 |
| Accrued Expenses | 12,123 | 15,757 | 17,392 | 18,047 | 8,421 |
| Other current liabilities | 1,124 | 66 | 227 | 415 | N/A |
| TOTAL | $26,023 | $22,194 | $32,444 | $33,258 | $31,649 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45,052 | 39,806 | 31,777 | 27,381 | 14,639 |
| Deferred Revenues | N/A | N/A | 9,572 | 8,060 | 20,990 |
| Other Non-Current Liabilities | 229,676 | 123,244 | 105,747 | 142 | 0 |
| TOTAL | $274,728 | $163,050 | $152,524 | $42,523 | $14,998 |
| Total Liabilities | $300,751 | $185,244 | $184,968 | $75,781 | $46,647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,450 | 54,888 | 54,008 | 41,730 | 39,593 |
| Common Shares | 59 | 55 | 54 | 41 | 40 |
| Retained earnings | -865,016 | -743,324 | -646,081 | -518,291 | -534,744 |
| Other shareholders' equity | 679 | 500 | 343 | 137 | 149 |
| TOTAL | $-10,937 | $25,934 | $109,842 | $94,361 | $68,590 |
| Total Liabilities And Equity | $289,814 | $211,178 | $294,810 | $170,142 | $115,237 |